SARS-COV-2 vaccine (University of Hawaii/Soligenix/Hawaii Biotech)

N/A

Report date: 2025/01/26 17:04:37

Base Information

Drug NameSARS-COV-2 vaccine (University of Hawaii/Soligenix/Hawaii Biotech)
Drug Alias Nameglycoprotein recombinant subunit vaccine (University of Hawaii/Soligenix/Hawaii Biotech)glycoprotein recombinant subunit vaccine (University of Hawaii/Soligenix/Hawaii Biotech)
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Hawaii System
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Hawaii SystemHawaii Biotech IncSoligenix Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A